| Phosphatidylinositol 4, 5-bisphosphate directs spermatid cell polarity and exocyst localization in Drosophila L Fabian, HC Wei, J Rollins, T Noguchi, JT Blankenship, K Bellamkonda, ... Molecular biology of the cell 21 (9), 1546-1555, 2010 | 53 | 2010 |
| Disrupting inflammation-associated CXCL8-CXCR1 signaling inhibits tumorigenicity initiated by sporadic-and colitis-colon cancer stem cells RC Fisher, K Bellamkonda, LA Molina, S Xiang, D Liska, SK Sarvestani, ... Neoplasia 21 (3), 269-281, 2019 | 37 | 2019 |
| The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model K Bellamkonda, NK Chandrashekar, J Osman, BC Selvanesan, S Savari, ... BMC cancer 16, 1-14, 2016 | 37 | 2016 |
| Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer K Bellamkonda, SR Satapathy, D Douglas, N Chandrashekar, ... Cancer letters 437, 13-24, 2018 | 33 | 2018 |
| Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer J Osman, S Savari, NK Chandrashekar, K Bellamkonda, D Douglas, ... Oncotarget 8 (21), 34773, 2017 | 29 | 2017 |
| Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model S Savari, NK Chandrashekar, J Osman, D Douglas, K Bellamkonda, ... Carcinogenesis 37 (5), 491-499, 2016 | 29 | 2016 |
| The WNT5A agonist Foxy5 reduces the number of colonic cancer stem cells in a xenograft mouse model of human colonic cancer J Osman, K Bellamkonda, Q Liu, T Andersson, A Sjölander Anticancer research 39 (4), 1719-1728, 2019 | 26 | 2019 |
| The impact of inflammatory lipid mediators on colon cancer‐initiating cells K Bellamkonda, W Sime, A Sjölander Molecular carcinogenesis 54 (11), 1315-1327, 2015 | 22 | 2015 |
| Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity M Rodriguez-Zabala, R Ramakrishnan, K Reinbach, S Ghosh, L Oburoglu, ... Blood Advances 7 (18), 5382-5395, 2023 | 6 | 2023 |
| Targeting SLC3A2 Sensitizes AML Cells Towards NK Cell-Mediated Killing K Bellamkonda, R Ramakrishnan, S Ghosh, K Reinbach, M Järås Blood 142, 167, 2023 | | 2023 |
| 2180 Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model J Osman, S Savari, NK Chandrashekar, D Douglas, K Bellamkonda, ... European Journal of Cancer 3 (51), S393, 2015 | | 2015 |
| The Role of Inflammatory Lipid Mediators on Colon Cancer Initiating Cells (CICs) K Bellamkonda Lund University Faculty of Medicine Doctoral Dissertation Series 2015 (18), 2015 | | 2015 |
| 899: Identifying genes involved in the colon cancer initiating cells (CICs) survivability against montelukast treatment in xenograft model K Bellamkonda, S Savari, N Chandrashekar, A Sjolander European Journal of Cancer, S220, 2014 | | 2014 |
| The impact of lipid inflammatory mediators on colon cancer initiating cells. A Sjölander, K Bellamkonda, W Sime Cancer Research 73 (8_Supplement), 3747-3747, 2013 | | 2013 |
| Foxy-5 J OSMAN, K BELLAMKONDA, Q LIU, T ANDERSSON, A SJÖLANDER | | |
